National Taiwan University, Taipei, Taiwan.
Neurorehabil Neural Repair. 2010 Jan;24(1):42-51. doi: 10.1177/1545968309345268. Epub 2009 Sep 3.
Most studies of bilateral arm training (BAT) did not employ a randomized controlled trial design and involved very limited functional training tasks.
Compare the effects of BAT with control intervention (CI) on motor control and motor performance of the upper extremity and also functional gains in patients with chronic stroke.
. This 2-group randomized controlled trial with pretreatment and posttreatment measures enrolled 33 stroke patients (mean age = 53.85 years) 6 to 67 months after onset of a first stroke. They received either a BAT program concentrating on both upper extremities moving simultaneously in functional tasks by symmetric patterns or CI (control treatment) for 2 hours on weekdays for 3 weeks. Outcome measures included kinematic analyses assessing motor control strategies for unilateral and bimanual reaching and clinical measures involving the Fugl-Meyer Assessment (FMA) of motor-impairment severity and the Functional Independence Measure (FIM) and the Motor Activity Log (MAL) evaluating functional ability.
After treatment, the BAT group showed better temporal and spatial efficiency during unilateral and bilateral tasks and less online error correction only during the bilateral task than the control group. The BAT group showed a significantly greater improvement in the FMA than the control group but not in the FIM and MAL.
Relative to CI, BAT improved the spatiotemporal control of the affected arm in both bilateral and unilateral tasks, decreased online corrections to perform bilateral tasks, and reduced motor impairment. These findings support the use of BAT to improve motor control and motor function of the affected upper limb in stroke patients.
大多数双侧手臂训练(BAT)的研究没有采用随机对照试验设计,且涉及的功能训练任务非常有限。
比较 BAT 与对照干预(CI)对慢性脑卒中患者上肢运动控制和运动表现的影响,以及对功能的改善效果。
本研究采用 2 组随机对照试验,在治疗前和治疗后进行评估,共纳入 33 例脑卒中患者(平均年龄=53.85 岁),发病后 6 至 67 个月。他们接受了为期 3 周、每周 5 天、每次 2 小时的 BAT 方案,该方案侧重于双侧上肢同时进行功能性任务的对称运动,或者接受 CI(对照治疗)。主要结局指标包括运动控制策略的运动学分析,评估单侧和双侧伸手的运动控制策略;临床指标包括 Fugl-Meyer 运动损伤严重程度评估(FMA)、功能独立性测量(FIM)和运动活动日志(MAL),评估运动功能。
治疗后,BAT 组在单侧和双侧任务中表现出更好的时间和空间效率,且仅在双侧任务中表现出较少的在线错误纠正,优于对照组。BAT 组的 FMA 改善程度显著优于对照组,但 FIM 和 MAL 无显著改善。
与 CI 相比,BAT 改善了脑卒中患者双侧和单侧任务中患侧上肢的时空控制,减少了执行双侧任务时的在线纠正,并降低了运动损伤。这些发现支持使用 BAT 改善脑卒中患者患侧上肢的运动控制和运动功能。